| 2014-06-12 | Sale | Haemonetics Corporation HAE | director | 13,368 0.0236% | $31.11 | $415,873 | +9.7% | |
| 2013-05-03 | Sale | Haemonetics Corporation HAE | director | 24,000 0.0394% | $32.35 | $776,390 | +5.35% | |
| 2011-02-07 | Sale | Haemonetics Corporation HAE | director | 22,695 0.0894% | $61.88 | $1.4M | +2.94% | |
| 2011-02-04 | Sale | Haemonetics Corporation HAE | director | 30,610 0.0786% | $40.76 | $1.25M | +1.78% | |
| 2010-12-01 | Sale | Myriad Genetics, Inc. MYGN | director | 130,000 0.143% | $21.55 | $2.8M | -4.48% | |
| 2010-11-30 | Sale | Myriad Genetics, Inc. MYGN | director | 50,000 0.0545% | $21.49 | $1.07M | -5.02% | |
| 2010-02-18 | Sale | Haemonetics Corporation HAE | director | 150,000 0.5882% | $53.42 | $8.01M | +5.65% | |
| 2010-02-17 | Sale | Haemonetics Corporation HAE | director | 75,000 0.2941% | $53.63 | $4.02M | +5.15% | |
| 2010-02-16 | Sale | Haemonetics Corporation HAE | director | 75,000 0.2948% | $53.55 | $4.02M | +5.51% | |
| 2007-05-03 | Sale | Boston Scientific Corporation BSX | EVP | 300,000 0.0202% | $16.26 | $4.88M | -19.8% | |
| 2007-05-02 | Sale | Boston Scientific Corporation BSX | EVP | 300,000 0.02% | $16.16 | $4.85M | -19.9% | |
| 2006-06-16 | Haemonetics Corporation HAE | director | 300,000 1.1167% | $46.56 | $13.97M | +0.57% | ||
| 2006-02-15 | Boston Scientific Corporation BSX | EVP | 200,000 0.0239% | $22.44 | $4.49M | -23.88% | ||
| 2004-05-26 | Sale | Boston Scientific Corporation BSX | EVP | 100,000 0.0016% | $6.13 | $613,000 | -22.69% | |
| 2004-04-07 | Sale | Boston Scientific Corporation BSX | EVP | 325,000 0.0386% | $45.10 | $14.66M | -20.09% | |
| 2004-04-06 | Sale | Boston Scientific Corporation BSX | EVP | 325,000 0.0384% | $45.49 | $14.78M | -21.03% | |
| 2004-04-05 | Sale | Boston Scientific Corporation BSX | EVP | 325,000 0.0378% | $45.03 | $14.64M | -21.65% | |
| 2004-03-05 | Sale | Boston Scientific Corporation BSX | EVP | 225,000 0.0038% | $6.13 | $1.38M | -14.27% | |
| 2004-01-30 | Sale | Boston Scientific Corporation BSX | EVP | 289,000 0.0336% | $40.04 | $11.57M | -5.37% | |
| 2004-01-29 | Sale | Boston Scientific Corporation BSX | EVP | 157,000 0.0032% | $6.94 | $1.09M | -3.35% |